| Literature DB >> 30354841 |
Sara Torretta1,2, Michele Gaffuri2, Tullio Ibba2, Pasquale Capaccio2,3, Paola Marchisio2,4, Antonella Maruca2, Samantha Bosis2, Lorenzo Pignataro1,2.
Abstract
Non-tuberculous mycobacterial lymphadenitis (NTML) accounts for about 95% of the cases of head-and-neck mycobacterial lymphadenitis, and its prevalence has been increasing in the Western world. The diagnostic work-up can be challenging, and differential diagnoses such as tuberculous and suppurative lymphadenitis need to be considered. It may, therefore, not be diagnosed until the disease is in a late stage, by which time it becomes locally destructive and is characterized by a chronically discharging sinus. The treatment options include a medical approach, a wait-and-see policy, and surgery, with the last being considered the treatment of choice despite the high risk of iatrogenic nerve lesions. The aim of this article is to provide an overview of pediatric, head-and-neck NTML based on the literature and our own experience, with particular emphasis on the impact and limitations of surgery.Entities:
Keywords: children; head and neck; lymphadenitis; non-tuberculous mycobacteria
Mesh:
Year: 2018 PMID: 30354841 PMCID: PMC6202736 DOI: 10.1177/2058738418806413
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN: 0394-6320 Impact factor: 3.219
Results of the included studies.
| Authors (year) | No. of patients | Mean age (range) | Site | Stage | Treatment | Cure rate | Complications |
|---|---|---|---|---|---|---|---|
| Flint et al. (2000)[ | 57 | 26.7 m (12 m–4 y) | SM = 47% | – | Excision = 19% | Excision = 91% | MM nerve dysfunction = 8% (after excision) |
| Lindeboom et al. (2007)[ | 100 | 45.5 m (9–168 m) | I = 18% | Excision = 50% | Excision = 96% | MM nerve dysfunction = 14% | |
| Harris et al. (2009)[ | 11 | 43 m (17 m–13 y) | SM = 82% | III | Excision | 100% | Temporary MM dysfunction = 18%; |
| Claesson et al. (2010)[ | 126 | 2.7 y (0.6–13 y) | Neck = 97% (groin = 3%) | – | Excision = 53% | 94% | Retropharyngeal abscess = 2% |
| Scott et al. (2012)[ | 43 | 33 m (11–130 m) | SM = 40% | I–II = 37% | Excision = 47% | Excision = 70% | Facial nerve dysfunction = 15% (after incision)
|
| Mahadevan et al. (2016)[ | 97 | 27 m (8 m–15 y) | SM = 46% | – | Excision = 37% | Excision = 81% | MM dysfunction = 7% (permanent = 4%, temporary = 3%)
|
| Rives et al. (2016)[ | 30 | 4.5 y (2–28 y) | SM = 53% | I = 35% | Surgery = 27% | Surgery = 75% | – |
| Tebruegge et al. (2016)[ | 107 | 2.6 y (2.1–3.8 y) | SM/neck[ | III = 15% | Excision = 97% | – | Facial nerve dysfunction = 7% |
M: months; y: years; SM: submandibular; P: parotid; MM: marginalis mandibulae.
Neck sites other than submandibular and parotid.
Incision and drainage/incision and curettage/aspiration.
Figure 1.Non-tuberculous mycobacterial lymphadenitis of the head and neck: stage II (a), stage III (b), and stage IV (c).
Figure 2.Intra-operative view of the strict anatomical relationship between stage IV non-tuberculous mycobacterial lymphadenitis and the adjacent spinal accessory nerve (arrow).